Article Details
Retrieved on: 2025-04-14 17:21:41
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article highlights Odylia Therapeutics' efforts in biopharma, particularly focusing on rare disease research, gene therapy, and genetic engineering for conditions like Usher syndrome. It emphasizes collaboration with biotech, bioethics, and patient groups to advance treatments.
Article found on: www.pharmexec.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here